Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Assets (2022 - 2025)

Historic Return on Assets for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to 1.02%.

  • TriSalus Life Sciences' Return on Assets rose 8400.0% to 1.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.02%, marking a year-over-year increase of 8400.0%. This contributed to the annual value of 1.24% for FY2024, which is 13100.0% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Return on Assets stood at 1.02%, which was up 8400.0% from 0.89% recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Return on Assets peaked at 0.19% during Q4 2022, and registered a low of 3.23% during Q2 2023.
  • Moreover, its 4-year median value for Return on Assets was 1.79% (2023), whereas its average is 1.7%.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -18500bps in 2023, then soared by 19900bps in 2025.
  • TriSalus Life Sciences' Return on Assets (Quarter) stood at 0.19% in 2022, then crashed by -997bps to 2.04% in 2023, then skyrocketed by 43bps to 1.17% in 2024, then rose by 13bps to 1.02% in 2025.
  • Its Return on Assets stands at 1.02% for Q3 2025, versus 0.89% for Q2 2025 and 1.03% for Q1 2025.